Rhodium & Coronavirus (IMAGE) Southwest Research Institute Caption SwRI's Rhodium™ virtual screening tool recently evaluated more than 40 million drug compounds in a week, with help from Department of Defense supercomputers, to identify high-probability drugs that may have efficacy against the coronavirus with minimal adverse side effects. SwRI recently received a $1.9 million, one-year contract to support efforts to develop a COVID-19 treatment from the Henry M. Jackson Foundation for the Advancement of Military Medicine. Credit Southwest Research Institute Usage Restrictions Images/videos may be used by the media and the public for educational and informational purposes only License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.